ArticleCancer immunology, immunotherapy : CII2012

Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activity.

Shuzhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.